Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Therapeutic Outcome of Combined Antihistaminics Therapy in COVID 19 Patients

NCT05043350 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05043350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Therapeutic Outcome of Combined Antihistaminics Therapy in COVID 19 Patients
Lead sponsor
Ain Shams University
Phase
Phase 2/3
Overall status
Completed
Start date
September 13, 2021
Completion date
July 30, 2022
Enrollment
214 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19